| Pharmaceutical manufacturing industry is one of the high technology industry,It’s about to the skill of the people’s livelihood.At the same time it also can promote the development of society, guarantee the public health, and create economic value.It is no doubt that pharmaceutical manufacturing industry has a good prospect.Pharmaceutical manufacturing industry has be highly regarded of the political and business all over the world.In order to compete for international market share, pharmaceutical companies in the developed countries to increase the investment of funds.In recent years our country medicine manufacturing industry also obtained the development which progresses by leaps and bounds,formed in shandong,jiangsu, zhejiang, three provinces of the pharmaceutical industry gathering area.Successful cases of pharmaceutical manufacturing in developed countries indicate that Pharmaceutical industry related companies in geographical space near,division of labor among enterprises is characteristic of cluster development in a large extent to promote the development of regional pharmaceutical manufacturing.Therefore, it is an important subject to study the relationship between industrial agglomeration and industrial competitiveness of Chinese pharmaceutical manufacturing industry. Industrial agglomerantion and industrial competitiveness of pharmaceutical manufacturing industry in our country are selected in this article Mainly carried on the following research work:First, Industrial agglomeration, Industrial competitiveness, the Industrial agglomeration and Industrial competitiveness relevant measure methods of literature at home and abroad are summarized. Summarizes the characteristics of Industrial agglomeration theory, Industrial agglomeration and the type of Industrial agglomeration. And through the literature review the interaction between Industrial concentration and Industrial competitiveness.Second, the paper adopt the method of location entropy index measure the2009-2014 of 31 provinces in China pharmaceutical manufacturing industry agglomeration level, according to the location entropy values of different provinces in pharmaceutical manufacturing output filter out the agglomeration conditions are 15 provinces of our country. Next, through the method of principal component analysis to calculate the 2009-2014 regional competitiveness score 30 provinces in our countrymedicine manufacturing, the study of our country medicine manufacturing competitiveness strong mainly concentrated in the central coastal region, represented by shandong, jiangsu, zhejiang, pharmaceutical manufacturing competitiveness present a strong east west weak situation as a whole. Using regression empirical method to study the agglomeration conditions are 15 provinces of the relationship between industrial agglomeration and industrial competitiveness, the study found that industrial agglomeration of industrial agglomeration has a certain role in promoting,but each province is different.Third, based on the above research from the national level and regional level put forward our country medicine manufacturing industry competitiveness, national level mainly includes: improve the industry concentration, consummate the medicine circulation system, enhance investment in innovation, training professional personnel,broaden the investment channels, reduce business risk from three aspects. At the regional level, the strong development of pharmaceutical manufacturing area, general areas and underdeveloped areas respectively puts forward the opinions of the medicine industry competitiveness. |
PDF Full Text Request